FDA gives orphan drug designation to AMP-L2.7.D7 for congenital erythropoietic porphyria April 25, 2018
FDA clears Ultragenyx's IND for phase I/II study of DTX-401 for glycogen storage disease type Ia April 24, 2018
RSS